EnteraGam

EnteraGam® uniquely binds toxic substances released by bacteria (and other substances called microbial components)¹ that upset the intestinal environment. This helps prevent them from penetrating the lining of the intestine and causing problems.

In a clinical study, people who took EnteraGam® experienced fewer days per week with loose stools and other IBS-D–related symptoms, including abdominal discomfort and bloating. Some people notice management of their condition with EnteraGam® in as little as 2 to 4 weeks.²

1 Horgan A, Maas K, Henderson A, Detzel C, Weaver E. Serum-derived bovine immunoglobulin/protein isolate binds to pathogen-associated molecular
patterns. Poster presented at: Federation of American Societies for Experimental Biology; April 26-30, 2014; San Diego, CA.

2 Wilson D, Evans M, Weaver E, Shaw AL, Klein GL. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with
diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol. 2013;6:49-60.